Publications by authors named "Jennifer Pfaff"

Claim this Profile
P
Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.
Leike Li, Weixu Meng, Melanie Horton, Daniel R DiStefano, Elizabeth A Thoryk, Jennifer M Pfaff

PLoS Pathog· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SELfies and CELLfies: Whole Genome Sequencing and Annotation of Five Antibiotic Resistant Bacteria Isolated from the Surfaces of Smartphones, An Inquiry Based Laboratory Exercise in a Genomics Undergraduate Course at the Rochester Institute of Technology.
Anutthaman Parthasarathy, Narayan H Wong, Amanda N Weiss, Susan Tian, Sara E Ali, Jennifer M Pfaff

J Genomics· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.
Radhika Gopal, Kelli Jackson, Netanel Tzarum, Leopold Kong, Andrew Ettenger, Jennifer M Pfaff

PLoS Pathog· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance.
Justin R Bailey, Andrew I Flyak, Valerie J Cohen, Hui Li, Lisa N Wasilewski, Jennifer M Pfaff

JCI Insight· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
Usha K Nivarthi, Nurgun Kose, Gopal Sapparapu, Douglas Widman, Emily Gallichotte, Jennifer M Pfaff

J Virol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Biologically-validated HCV E1E2 Heterodimer Structural Model.
Matteo Castelli, Nicola Clementi, Jennifer Pfaff, Giuseppe A Sautto, Roberta A Diotti

Sci Rep· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
Meihui Xu, Roland Züst, Ying Xiu Toh, Jennifer M Pfaff, Kristen M Kahle

J Virol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1.
William B Messer, Boyd L Yount, Scott R Royal, Ruklanthi de Alwis, Douglas G Widman, Jennifer M Pfaff

J Virol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response.
Elizabeth Ernestina Godoy-Lozano, Juan Téllez-Sosa, Gilberto Sánchez-González, Hugo Sámano-Sánchez, Andrés Aguilar-Salgado, Jennifer M Pfaff

Genome Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.
Scott A Smith, Usha K Nivarthi, Ruklanthi de Alwis, Nurgun Kose, Gopal Sapparapu, Jennifer M Pfaff

J Virol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.
Edgar Davidson, Christopher Bryan, Rachel H Fong, Trevor Barnes, Jennifer M Pfaff

J Virol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV E2 core structures and mAbs: something is still missing.
Matteo Castelli, Nicola Clementi, Giuseppe A Sautto, Jennifer Pfaff, Kristen M Kahle

Drug Discov Today· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.
William B Messer, Ruklanthi de Alwis, Boyd L Yount, Scott R Royal, Jeremy P Huynh, Jennifer M Pfaff

Proc Natl Acad Sci U S A· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomic-level functional model of dengue virus Envelope protein infectivity.
Elizabeth A Christian, Kristen M Kahle, Kimberly Mattia, Bridget A Puffer, Jennifer M Pfaff

Proc Natl Acad Sci U S A· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.
Scott A Smith, A Ruklanthi de Alwis, Nurgun Kose, Eva Harris, Kristie D Ibarra, Jennifer M Pfaff

mBio· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
Nicholas F Parrish, Craig B Wilen, Lauren B Banks, Shilpa S Iyer, Jennifer M Pfaff

PLoS Pathog· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary infection by a human immunodeficiency virus with atypical coreceptor tropism.
Chunlai Jiang, Nicholas F Parrish, Craig B Wilen, Hui Li, Yue Chen, Jennifer M Pfaff

J Virol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.
Craig B Wilen, Nicholas F Parrish, Jennifer M Pfaff, Julie M Decker, Elizabeth A Henning

J Virol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells.
Jennifer M Pfaff, Craig B Wilen, Jessamina E Harrison, James F Demarest, Benhur Lee

J Virol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry.
John C Tilton, Heather Amrine-Madsen, John L Miamidian, Kathryn M Kitrinos, Jennifer Pfaff

AIDS Res Hum Retroviruses· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis